Target intelligence / Profile preview

Neuroblastoma breakpoint family member 11 (NBPF11)

Target
NBPF11
Molecular classification
Other (protein-coding gene of unknown/miscellaneous molecular function, family: Neuroblastoma breakpoint family)
01

Overview

Neuroblastoma breakpoint family member 11 (NBPF11) is a protein encoded by the NBPF11 gene in humans, belonging to the neuroblastoma breakpoint (NBPF) family. The NBPF family comprises multiple, highly related genes mostly located on chromosome 1, characterized by repetitive exon structures and a high degree of sequence homology. NBPF11 is predicted to reside in the cytoplasm, contains two coiled-coil regions and six Olduvai domains (conserved regions of uncertain function). Its function remains unknown, and its association with disease is based largely on genomic position and family-level implications (e.g., involvement of NBPF genes in neuroblastoma and chromosomal syndromes). There is currently no established role for NBPF11 as a drug target or clinical biomarker, nor are there known drugs or safety concerns specifically connected to this protein.

Other names
NBPF24Neuroblastoma breakpoint family member 24NBPFB_HUMAN (UniProt entry)NBPF member 11neuroblastoma breakpoint family, member 11Chromosome 1Q21.1 Deletion Syndrome gene (contextual disease association)
02

Mechanism of action

None known (no drugs targeting NBPF11 are identified)

03

Biological functions

Other (functions currently unknown; predicted cytoplasmic localization)
04

Disease associations

Cancer (NBPF gene family disruptions are implicated in neuroblastoma and possibly other tumors, but direct links for NBPF11 are not established)Chromosome 1Q21.1 Deletion SyndromeChromosome 1Q21.1 Duplication Syndrome

Beyond the preview

Go deeper on Neuroblastoma breakpoint family member 11 (NBPF11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroblastoma breakpoint family member 11 (NBPF11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call